MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12868-015-0236-5

Медицинская библиотека · BMC neuroscience · 2016

SP, CGRP changes in pyridoxine induced neuropathic dogs with nerve growth factor gene therapy.

Kang Joo-Yeon, Yoo Dae Young, Lee Kwon-Young, Im Wooseok, Kim Manho, Choi Jung Hoon, Youn Hwa-Young, Kim Sae Hoon, Hwang In Koo, Chung Jin-Young

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Nerve growth factor (NGF) is known not only as a major factor for neuronal plasticity but also as a pain stimulator. Although there have been several trials with NGF for its application in the regeneration or protection of the nervous system, the pain induced by NGF remains a challenge to be overcome. In this study, the pain induced by NGF gene therapy was evaluated.

RESULTS

Vehicle or recombinant dog NGF plasmid was administered into the intrathecal space of dogs. Twenty-four hours after the vehicle or NGF plasmid inoculation, dogs were subcutaneously treated with 150 mg/kg pyridoxine every day for 7 days. For pain assessment, physical examination and electrophysiological recording were performed. Only in the vehicle-treated group, weight loss occurred, while NGF plasmid inoculation significantly improved this physical abnormalities. In the vehicle-treated group, electrophysiological recordings showed that H-reflex disappeared at 24 h after the last pyridoxine treatment. However, in the NGF plasmid inoculated group, the H-reflex were normal. In the results of immunohistochemistry, the NGF plasmid administration efficiently expressed in the dorsal root ganglia and significantly increased the pyridoxine-induced reduction of calcitonin gene-related peptide (CGRP) immunoreactive neurons, but not in substance P immunoreactive neurons, in the dorsal root ganglia.

CONCLUSIONS

Given these results, we reason that NGF gene therapy in pyridoxine induced neuropathic dogs does not induce neuropathic pain with this dosage, even with increasing the expression of CGRP.

Для цитирования: Kang Joo-Yeon, Yoo Dae Young, Lee Kwon-Young, Im Wooseok, Kim Manho, Choi Jung Hoon, Youn Hwa-Young, Kim Sae Hoon, Hwang In Koo, Chung Jin-Young. SP, CGRP changes in pyridoxine induced neuropathic dogs with nerve growth factor gene therapy.. BMC neuroscience. 2016. DOI: 10.1186/s12868-015-0236-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.